NCT05761444View on ClinicalTrials.gov

Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

September 4, 2024

Study Completion Date

October 15, 2024

Conditions
Atherosclerotic Cardiovascular Disease
Interventions
DRUG

Atozet 10/40 mg or 10/80 mg

Atozet 10/40 mg or 10/80 mg Dosage Formulation: Tablet Dosing Instructions: oral. Take 1 tablet daily

DRUG

Lipitor 40 mg or 80 mg

Lipitor 40 mg or 80 mg Dosage Formulation: Tablet Dosing Instructions: oral. Take 1 tablet daily

Trial Locations (7)

10380

Inje University Ilsan-Paik Hospital, Goyang-si

13620

Seoul National University Bundang Hospital, Seongnam-si

42601

Keimyung University Dongsan Medical Center, Daegu

44033

Ulsan University Hospital, Ulsan

61469

Chonnam National University Hospital, Gwangju

03312

Eunpyeong St. Mary's Hospital, Seoul

03181

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Organon and Co

INDUSTRY